Search

Your search keyword '"Banfi, Carlo"' showing total 318 results
Start Over Author "Banfi, Carlo"
318 results on '"Banfi, Carlo"'

2. Midterm outcomes with a sutureless aortic bioprosthesis in a prospective multicenter cohort study

Author

Zannis, Kostantinos, Pfeiffer, Steffen, Santarpino, Giuseppe, Shrestha, Malakh, Sarikouch, Samir, Gummert, Jan F., Mohr, Friedrich W., Dohmen, Pascal, Stalder, Mario, Roost, Eva, Filipiak, Krzysztof, Niklewski, Tomasz, Madonna, Francesco, Roques, Xavier, Flameng, Willem J., Laczkovics, Axel M.M., Bechtel, Matthias, Prat, Alain G., Banfi, Carlo, Dapunt, Otto E., Eichstaedt, Harald C., Harringer, Wolfgang, Carstens-Fitz, Ulrike, Spyt, Tom J., Wimmer-Greinecker, Jan Gerhard, Machner, Matthias, Tan, Erwin S.H., Casselman, Filip P.A., Yilmaz, Alaaddin, Sonker, Uday, Bleiziffer, Sabine, Oberwalder, Peter J., Kocher, Alfred A., Seitelberger, Rainald, Treede, Hendrik, Conradi, Leonard, Cocchieri, Riccardo, De Mol, Bas, Roussel, Jean-Christian, Despins, Philippe, Jakob, Heinz G., Wendt, Daniel, Fischlein, Theodor, Meuris, Bart, Folliguet, Thierry, Hakim-Meibodi, Kavous, Misfeld, Martin, Carrel, Thierry, Zembala, Marian, Cerutti, Elisa, Asch, Federico M., and Haverich, Axel

Published
2022
Full Text
View/download PDF

8. Improved Extracorporeal Cardiopulmonary Resuscitation (ECPR) Outcomes are Associated with a Restrictive Patient Selection Algorithm.

Author

Assouline, Benjamin, Mentha, Nathalie, Wozniak, Hannah, Donner, Viviane, Looyens, Carole, Suppan, Laurent, Larribau, Robert, Banfi, Carlo, Bendjelid, Karim, and Giraud, Raphaël

Subjects
PATIENT selection, CARDIOPULMONARY resuscitation, TECHNOLOGICAL innovations, ALGORITHMS, CARDIAC arrest
Abstract

Introduction: Out-of-hospital cardiac arrest (OHCA) is a leading cause of mortality. Despite decades of intensive research and several technological advancements, survival rates remain low. The integration of extracorporeal cardiopulmonary resuscitation (ECPR) has been recognized as a promising approach in refractory OHCA. However, evidence from recent randomized controlled trials yielded contradictory results, and the criteria for selecting eligible patients are still a subject of debate. Methods: This study is a retrospective analysis of refractory OHCA patients treated with ECPR. All adult patients who received ECPR, according to the hospital algorithm, from 2013 to 2021 were included. Two different algorithms were used during this period. A "permissive" algorithm was used from 2013 to mid-2016. Subsequently, a revised algorithm, more "restrictive", based on international guidelines, was implemented from mid-2016 to 2021. Key differences between the two algorithms included reducing the no-flow time from less than three minutes to zero minutes (implying that the cardiac arrests must occur in the presence of a witness with immediate CPR initiation), reducing low-flow duration from 100 to 60 min, and lowering the age limit from 65 to 55 years. The aim of this study is to compare these two algorithms (permissive (1) and restrictive (2)) to determine if the use of a restrictive algorithm was associated with higher survival rates. Results: A total of 48 patients were included in this study, with 23 treated under Algorithm 1 and 25 under Algorithm 2. A significant difference in survival rate was observed in favor of the restrictive algorithm (9% vs. 68%, p < 0.05). Moreover, significant differences emerged between algorithms regarding the no-flow time (0 (0–5) vs. 0 (0–0) minutes, p < 0.05). Survivors had a significantly shorter no-flow and low-flow time (0 (0–0) vs. 0 (0–3) minutes, p < 0.01 and 40 (31–53) vs. 60 (45–80) minutes, p < 0.05), respectively. Conclusion: The present study emphasizes that a stricter selection of OHCA patients improves survival rates in ECPR. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Drug-induced aortic valve stenosis: An under recognized entity

Author

Ennezat, Pierre-Vladimir, Bruneval, Patrick, Czitrom, Daniel, Gueffet, Jean-Pierre, Piriou, Nicolas, Trochu, Jean Noël, Patra, Odile, Blanchard-Lemoine, Bénédicte, du Fretay, Xavier Halna, Nazeyrollas, Pierre, Assoun, Bernard, Jobic, Yannick, Brochet, Eric, Bogino, Emmanuel, Roudaut, Raymond, Augier, Caroline, Greffe, Lorraine, Petit-Eisenmann, Hélène, Dambrin, Camille, Chavanon, Olivier, Guillou, Louis, Grisoli, Dominique, Morera, Pierre, Banfi, Carlo, Remadi, Jean Paul, Fabre, Olivier, Vincentelli, André, Lantuejoul, Sylvie, Ikoli, Jean-Fortuné, Copin, Marie-Christine, Malergue, Marie-Christine, Maréchaux, Sylvestre, and Tribouilloy, Christophe

Published
2016
Full Text
View/download PDF

11. The sutureless aortic valve at 1 year: A large multicenter cohort study

Author

Folliguet, Thierry, Zannis, Kostantinos, Pfeiffer, Steffen, Santarpino, Giuseppe, Shrestha, Malakh, Sarikouch, Samir, Gummert, Jan F., Mohr, Friedrich W., Dohmen, Pascal, Stalder, Mario, Roost, Eva, Filipiak, Krzysztof, Niklewski, Tomasz, Roques, Xavier, Flameng, Willem J., Laczkovics, Axel M.M., Bechtel, Matthias, Prat, Alain G., Banfi, Carlo, Dapunt, Otto E., Eichstaedt, Harald C., Harringer, Wolfgang, Carstens-Fitz, Ulrike, Spyt, Tom J., Wimmer-Greinecker, Jan Gerhard, Machner, Matthias, Tan, Erwin S.H., Casselman, Filip P.A., Yilmaz, Alaaddin, Sonker, Uday, Bleiziffer, Sabine, Oberwalder, Peter J., Kocher, Alfred A., Seitelberger, Rainald, Treede, Hendrik, Conradi, Leonard, Cocchieri, Riccardo, De Mol, Bas, Roussel, Jean-Christian, Despins, Philippe, Jakob, Heinz G., Wendt, Daniel, Fischlein, Theodor, Meuris, Bart, Hakim-Meibodi, Kavous, Misfeld, Martin, Carrel, Thierry, Zembala, Marian, Gaggianesi, Sara, Madonna, Francesco, Laborde, François, Asch, Federico, and Haverich, Axel

Published
2016
Full Text
View/download PDF

15. Midterm outcomes with a sutureless aortic bioprosthesis in a prospective multicenter cohort study

Author

Fischlein, Theodor, primary, Meuris, Bart, additional, Folliguet, Thierry, additional, Hakim-Meibodi, Kavous, additional, Misfeld, Martin, additional, Carrel, Thierry, additional, Zembala, Marian, additional, Cerutti, Elisa, additional, Asch, Federico M., additional, Haverich, Axel, additional, Zannis, Kostantinos, additional, Pfeiffer, Steffen, additional, Santarpino, Giuseppe, additional, Shrestha, Malakh, additional, Sarikouch, Samir, additional, Gummert, Jan F., additional, Mohr, Friedrich W., additional, Dohmen, Pascal, additional, Stalder, Mario, additional, Roost, Eva, additional, Filipiak, Krzysztof, additional, Niklewski, Tomasz, additional, Madonna, Francesco, additional, Roques, Xavier, additional, Flameng, Willem J., additional, Laczkovics, Axel M.M., additional, Bechtel, Matthias, additional, Prat, Alain G., additional, Banfi, Carlo, additional, Dapunt, Otto E., additional, Eichstaedt, Harald C., additional, Harringer, Wolfgang, additional, Carstens-Fitz, Ulrike, additional, Spyt, Tom J., additional, Wimmer-Greinecker, Jan Gerhard, additional, Machner, Matthias, additional, Tan, Erwin S.H., additional, Casselman, Filip P.A., additional, Yilmaz, Alaaddin, additional, Sonker, Uday, additional, Bleiziffer, Sabine, additional, Oberwalder, Peter J., additional, Kocher, Alfred A., additional, Seitelberger, Rainald, additional, Treede, Hendrik, additional, Conradi, Leonard, additional, Cocchieri, Riccardo, additional, De Mol, Bas, additional, Roussel, Jean-Christian, additional, Despins, Philippe, additional, Jakob, Heinz G., additional, and Wendt, Daniel, additional

Published
2022
Full Text
View/download PDF

19. David Procedure: A 21-year Experience With 300 Patients.

Author

Manganiello, Sabrina, Soquet, Jerome, Mugnier, Agnes, Rousse, Natacha, Juthier, Francis, Banfi, Carlo, Loobuyck, Valentin, Coisne, Augustin, Richardson, Marjorie, Marechaux, Sylvestre, Moussa, Mouhamed Djahoum, Robin, Emmanuel, Pinçon, Claire, Prat, Alain, and Vincentelli, Andre

Abstract

Valve-sparing aortic root replacement with the David procedure is an alternative to the Bentall procedure in patients with aortic root aneurysm. The aim of this study was to describe our long-term experience with this technique and the predictive factors of late failure. Between January 1998 and August 2019, 300 consecutive patients underwent a David procedure. Clinical and echocardiographic early- and long-term outcomes were analyzed. Median follow-up was 7.0 years (range, 4.1-11.5), with 98.3% complete. Early mortality was 1%. No early valve-related reoperations occurred. There were 9 cardiac-related deaths and 22 reinterventions (19 valve-related). All patients survived reoperation. In 3 patients reintervention consisted of transcatheter aortic valve implantation. Overall survival rates were 95.3% (95% confidence interval [CI], 92.0-97.2), 91.1% (95% CI, 86.5-94.2), and 82.9% (95% CI, 75.3-88.4) at 5, 10, and 15 years, respectively. Freedom from postoperative aortic insufficiency (AI) grade ≥ 2 was 84.8% (95% CI, 79.9-88.6) and 74.3% (95% CI, 67.4-79.9) at 5 and 10 years, respectively. Freedom from reintervention for aortic valve disease was 97.1% (95% CI, 94.2-98.5), 92.9% (95% CI, 88.2-95.7), and 92.5% (95% CI, 87.1-95.7) at 5, 10, and 15 years, respectively. Preoperative AI ≥ 2 (hazard ratio, 1.782; 95% CI, 1.352-2.350) and a ventriculoaortic junction ≥ 29 mm (hazard ratio, 3.379; 95% CI, 1.726-6.616) were predictive factors for postoperative AI ≥ 2 in a multivariate analysis (P <.001). Preoperative AI ≥ 2 and a ventriculoaortic junction ≥ 29 mm were identified as risk factors for late postoperative AI ≥ 2. [Display omitted] [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

20. Impella 5.0 supported oncological surgery as bridge to LVAD

Author

Montisci, Andrea, Micheletto, Giancarlo, Sibilio, Serena, Donatelli, Francesco, Tespili, Maurizio, Banfi, Carlo, Casilli, Francesco, Cosseta, Daniele, Miceli, Antonio, Cirri, Silvia, and Pappalardo, Federico

Subjects
Myocardial infarction, lcsh:Diseases of the circulatory (Cardiovascular) system, Cariogenic shock, Mechanical circulatory support, lcsh:RC666-701, Case Report, Left ventricular assist device, Case Reports, Cancer
Abstract

We describe the case of a 58‐year‐old man presenting with myocardial infarction complicated by cardiogenic shock, treated with Impella CP which was escalated to an axillary 5.0 due to lack of cardiac recovery. Weaning from Impella 5.0 failed, and the patient was evaluated for heart transplantation (HTx) or left ventricular assist device (LVAD). HTx was excluded because of a rectal adenocarcinoma. The patient underwent colorectal surgery while on Impella. Perioperative course was uneventful. After 61 days of Impella, when the LVAD implantation was scheduled, the patient died due to K. pneumoniae infection.

Published
2021

21. David Procedure: A 21-Year Experience with 300 Patients

Author

Manganiello, Sabrina, primary, Soquet, Jerome, additional, Mugnier, Agnes, additional, Rousse, Natacha, additional, Juthier, Francis, additional, Banfi, Carlo, additional, Loobuyck, Valentin, additional, Coisne, Augustin, additional, Richardson, Marjorie, additional, Marechaux, Sylvestre, additional, Moussa, Mouhamed Djahoum, additional, Robin, Emmanuel, additional, Pinçon, Claire, additional, Prat, Alain, additional, and Vincentelli, Andre, additional

Published
2022
Full Text
View/download PDF

31. ECMO in Cardiac Arrest: A Narrative Review of the Literature

Author

de Charrière, Amandine Solange Marie, Assouline, Benjamin, Scheen, Marc, Mentha, Nathalie, Banfi, Carlo, Bendjelid, Karim, and Giraud, Raphaël

Subjects
ddc:617, Extracorporeal membrane oxygenation, ECMO, ECPR, Cardiac arrest
Abstract

Cardiac arrest (CA) is a frequent cause of death and a major public health issue. To date, conventional cardiopulmonary resuscitation (CPR) is the only efficient method of resuscitation available that positively impacts prognosis. Extracorporeal membrane oxygenation (ECMO) is a complex and costly technique that requires technical expertise. It is not considered standard of care in all hospitals and should be applied only in high-volume facilities. ECMO combined with CPR is known as ECPR (extracorporeal cardiopulmonary resuscitation) and permits hemodynamic and respiratory stabilization of patients with CA refractory to conventional CPR. This technique allows the parallel treatment of the underlying etiology of CA while maintaining organ perfusion. However, current evidence does not support the routine use of ECPR in all patients with refractory CA. Therefore, an appropriate selection of patients who may benefit from this procedure is key. Reducing the duration of low blood flow by means of performing high-quality CPR and promoting access to ECPR, may improve the survival rate of the patients presenting with refractory CA. Indeed, patients who benefit from ECPR seem to carry better neurological outcomes. The aim of this present narrative review is to present the most recent literature available on ECPR and to clarify its potential therapeutic role, as well as to provide an in-depth explanation of equipment and its set up, the patient selection process, and the patient management post-ECPR.

Published
2021

38. Utilisation de l'épuration extra-corporelle de dioxyde de carbone dans l'exacerbation de la maladie pulmonaire obstructive chronique: une revue narrative

Author

d'Andrea, Alexia, Banfi, Carlo, Bendjelid, Karim, and Giraud, Raphaël

Subjects
ddc:616, ddc:617
Abstract

L'exacerbation de la maladie pulmonaire obstructive chronique (MPOC) induit une acidose respiratoire hypercapnique. L'élimination extracorporelle du dioxyde de carbone (ECCO2R) vise à éliminer le dioxyde de carbone (CO2) sanguin afin de lutter contre les effets néfastes de l'hypercapnie et de l'acidose secondaire. L'hypercapnie a des conséquences extra-pulmonaires délétères en augmentant la pression intracrânienne et en induisant et/ou aggravant une insuffisance cardiaque droite. Au cours d'une exacerbation de MPOC, l'utilisation d'ECCO2R pourrait améliorer l'efficacité de la ventilation non-invasive (VNI) en termes d'élimination du CO2, diminuer la fréquence respiratoire et réduire l'hyperinflation dynamique et la pression expiratoire positive intrinsèque, phénomènes qui contribuent à l'augmentation de l'espace mort. L'ECCO2R pourrait donc permettre de diminuer les échecs de VNI et faciliter le sevrage ventilatoire des patients intubés sous ventilation mécanique. Dans cette revue de la littérature, nous présenterons les connaissances actuelles sur la physiopathologie liée à la MPOC, les principes de la technique d'ECCO2R et sa place dans les décompensations aigües et sévères de MPOC. Cependant, malgré les avancées techniques, il n'existe dans la littérature que des séries de cas et peu d'études prospectives permettant d'établir clairement le rôle de l'ECCO2R dans les décompensations aigües et sévères de MPOC.

Published
2020

42. Impella 5.0 supported oncological surgery as bridge to LVAD

Author

Montisci, Andrea, primary, Micheletto, Giancarlo, additional, Sibilio, Serena, additional, Donatelli, Francesco, additional, Tespili, Maurizio, additional, Banfi, Carlo, additional, Casilli, Francesco, additional, Cosseta, Daniele, additional, Miceli, Antonio, additional, Cirri, Silvia, additional, and Pappalardo, Federico, additional

Published
2020
Full Text
View/download PDF

45. Clinical and Echocardiographic Correlates of Plasma B-type Natriuretic Peptide Levels in Patients with Aortic Valve Stenosis and Normal Left Ventricular Ejection Fraction

Author

Maréchaux, Sylvestre, Hattabi, Mehdi, Juthier, Francis, Neicu, Dan Valentin, Richardson, Marjorie, Carpentier, Emilie, Bouabdallaoui, Nadia, Delelis, François, Banfi, Carlo, Breyne, Joke, Jude, Brigitte, Asseman, Philippe, Vincentelli, André, Le Tourneau, Thierry, Graux, Pierre, Pibarot, Philippe, and Ennezat, Pierre Vladimir

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results